Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Bitget VIP Weekly Research Insights
VIPBitget VIP Weekly Research Insights

Global risk assets are entering a phase where multiple catalysts are aligning, driving a new wave of momentum in technology and growth stocks. Trump has revived his "tariff dividend" proposal (a $2000 check per person), the U.S. government shutdown crisis is nearing resolution (with fiscal spending expected to resume before December 11), and the probability of a Fed rate cut in December has surged to 95% (with markets even partially pricing in a 50-basis-point cut). Expectations of ample liquidity are rising across the board. U.S. tech stocks and high-beta growth names are positioned to benefit first. Themes such as AI infrastructure, retail brokers (supported by the convergence of crypto and U.S. stock trading), and digital-asset infrastructure are likely to lead the rally. The Nasdaq index is expected to see further upside in the near term, while select quality stocks offer notable rebound potential. As a globally leading Universal Exchange (UEX), Bitget has fully integrated tokenized stocks and futures products, bridging traditional finance with the wider digital-asset ecosystem. Through strategic partnerships with institutions such as Ondo Finance, Bitget Onchain now supports on-chain tokenized trading for more than 100 stocks and ETFs. Users can trade tokenized stocks—including NVDA, HOOD, TSLA, MSTR, COIN, META, and other popular names—directly in the spot market, and also access perpetual futures on individual stocks within Bitget's futures section.

Bitget·2025/12/12 09:06
Flash
09:23
Roche Chairman still expects diagnostic products to be impacted by US tariffs
Gelonghui, March 7th|Roche Group Chairman Severin Schwan stated on Saturday that Roche expects its agreement with the US government will exempt its pharmaceuticals from the current round of import tariffs. However, its diagnostics division still faces risks and may be subject to new tariffs after the initial 150-day period expires. Schwan said that Roche's diagnostics division had sales close to 14 billion Swiss francs in 2025, with most of its tests and instruments exported to the US from Switzerland and other European countries.
09:16
The US SOL spot ETF saw a single-day net outflow of $8.2255 million.
PANews, March 7 – According to SoSoValue data, on March 6 (EST), the total daily net outflow of SOL spot ETF was $8.2255 million. Among them, one exchange recorded a daily net inflow of $426,900, with the current historical total net inflow reaching $2.1473 million. Another exchange saw a daily net outflow of $4.9974 million, with the current historical total net outflow reaching $10.2586 million. As of press time, the total net asset value of the SOL spot ETF is $807 million, with a SOL net asset ratio of 1.66%. The historical cumulative net inflow has reached $958 million.
09:12
Cerebras Systems hires Morgan Stanley to assist in restarting IPO plans
AI chip manufacturer Cerebras Systems has selected Morgan Stanley as the lead underwriter for its initial public offering (IPO) and plans to make another attempt at going public. According to some sources familiar with the matter, the fundraising scale may be around $2 billion, with the earliest possible launch in April. Another source stated that Cerebras has resubmitted its IPO filing and plans to meet with analysts and potential investors this month. Discussions are still ongoing, and specific details of the IPO may change.
VIP news